Therabel Gienne Pharma

Therabel Gienne Pharma is the Italian subsidiary of the Therabel Group, a privately owned European pharmaceutical company. The company was established in its current form following the acquisition of the Italian firm Gienne Pharma in 2012. It focuses on the commercialization and distribution of pharmaceutical products across several therapeutic areas, including gastroenterology, cardiology, and pain management. Therabel Gienne Pharma operates as a specialty pharmaceutical entity, leveraging partnerships with major global firms to bring both proprietary and licensed treatments to the Italian healthcare market. Its portfolio includes well-known brands such as Lucen for gastric acid disorders and Angitil for cardiovascular conditions. The company is headquartered in Milan and maintains a dedicated sales force to support its commercial operations throughout Italy.